1. Home
  2. SSTK vs COLL Comparison

SSTK vs COLL Comparison

Compare SSTK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$16.01

Market Cap

596.1M

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.42

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTK
COLL
Founded
2003
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
596.1M
1.2B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SSTK
COLL
Price
$16.01
$32.42
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$25.00
$51.17
AVG Volume (30 Days)
271.5K
547.7K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
8.76%
N/A
EPS Growth
23.76
N/A
EPS
1.25
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$4.35
$5.93
Revenue Next Year
N/A
N/A
P/E Ratio
$13.14
$19.32
Revenue Growth
N/A
23.62
52 Week Low
$14.35
$23.23
52 Week High
$29.50
$50.79

Technical Indicators

Market Signals
Indicator
SSTK
COLL
Relative Strength Index (RSI) 41.19 24.32
Support Level $15.75 $31.01
Resistance Level $17.81 $32.92
Average True Range (ATR) 0.61 1.30
MACD 0.02 -0.04
Stochastic Oscillator 14.97 1.07

Price Performance

Historical Comparison
SSTK
COLL

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: